Fidelity Investments’s Korro Bio KRRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$440K Buy
38,900
+1,043
+3% +$11.5K ﹤0.01% 3177
2025
Q4
$303K Sell
37,857
-525,824
-93% -$12.3M ﹤0.01% 3270
2025
Q3
$27M Sell
563,681
-75,541
-12% -$1.68M ﹤0.01% 1653
2025
Q2
$7.98M Sell
639,222
-4,047
-0.6% -$58.3K ﹤0.01% 2020
2025
Q1
$11.2M Buy
643,269
+1,530
+0.2% +$45.4K ﹤0.01% 1869
2024
Q4
$24.4M Buy
641,739
+62,176
+11% +$3.2M ﹤0.01% 1652
2024
Q3
$19.4M Sell
579,563
-59,562
-9% -$2.51M ﹤0.01% 1717
2024
Q2
$21.6M Sell
639,125
-88,080
-12% -$4.87M ﹤0.01% 1620
2024
Q1
$63.4M Hold
727,205
﹤0.01% 1231
2023
Q4
$32.6M Buy
+727,205
New +$24M ﹤0.01% 1454
2023
Q1
Sell
-11
Closed -$2.13K 5420
2022
Q4
$2.13K Hold
11
﹤0.01% 4499
2022
Q3
$1K Hold
11
﹤0.01% 4693
2022
Q2
$1K Sell
11
-20
-65% -$1.35K ﹤0.01% 4747
2022
Q1
$3K Buy
+31
New +$5.92K ﹤0.01% 4569
2021
Q4
Hold
0
4687
2021
Q2
Sell
-367
Closed -$174K 4593
2021
Q1
$174K Hold
367
﹤0.01% 2845
2020
Q4
$647K Sell
367
-94
-20% -$124K ﹤0.01% 2606
2020
Q3
$443K Sell
461
-1,304
-74% -$1.4M ﹤0.01% 2552
2020
Q2
$2.05M Hold
1,765
﹤0.01% 2274
2020
Q1
$1.57M Hold
1,765
﹤0.01% 2242
2019
Q4
$1.55M Buy
+1,765
New +$1.37M ﹤0.01% 2315

Other funds holding KRRO

Fidelity Investments's KRRO Position: Q1 2026 in Review

Fidelity Investments increased its Korro Bio (KRRO) stake by 2.8% in Q1 2026, buying an estimated $11.5K and bringing the position to 38,900 shares worth $440K. The position accounts for ﹤0.01% of the portfolio, ranked #3177.

Fidelity Investments first reported a position in KRRO in Q4 2019 and has held it in 20 quarters since. The position peaked at $63.4M in Q1 2024. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • Fidelity Investments held 38,900 shares of Korro Bio worth $440K as of Q1 2026.
  • Fidelity Investments bought 1,043 Korro Bio shares in Q1 2026, an estimated $11.5K.
  • Korro Bio made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #3177 holding.
  • Fidelity Investments first reported a position in Korro Bio in Q4 2019 and has held it in 20 quarters since.
  • Fidelity Investments's Korro Bio position peaked at $63.4M in Q1 2024.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.